Preview: S&T Bancorp’s Earnings

S&T Bancorp (NASDAQ:STBA) is set to give its latest quarterly earnings report on Thursday, 2022-07-21. Here's what investors need to know before the announcement. Analysts estimate that S&T Bancorp will report an earnings per share (EPS) of $0.65.

S&T Bancorp (NASDAQ:STBA) is set to give its latest quarterly earnings report on Thursday, 2022-07-21. Here’s what investors need to know before the announcement.

Analysts estimate that S&T Bancorp will report an earnings per share (EPS) of $0.65.

S&T Bancorp bulls will hope to hear the company to announce they’ve not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).

Historical Earnings Performance

Last quarter the company beat EPS by $0.15, which was followed by a 2.04% drop in the share price the next day.

Here’s a look at S&T Bancorp’s past performance and the resulting price change:

Quarter Q1 2022 Q4 2021 Q3 2021 Q2 2021
EPS Estimate 0.59 0.63 0.62 0.69
EPS Actual 0.74 0.57 0.70 0.72
Price Change % -2.04% -0.59% 1.68% 1.99%

eps graph

Stock Performance

Shares of S&T Bancorp were trading at $28.85 as of July 19. Over the last 52-week period, shares are up 0.35%. Given that these returns are generally positive, long-term shareholders should be satisfied going into this earnings release.

To track all earnings releases for S&T Bancorp visit their earnings calendar on our site.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Total
0
Shares
Related Posts
Read More

CBD Of Denver’s Success In Challenging Climate With Increase In Q4 Revenue

CBD of Denver has reported strong fourth-quarter revenues of approximately $1.31m, with $1.13m generated by Luxora and $176,000 by Libra 9. The CBD company attributed its growth to a number of factors, including its partnership with EDEKA and the popularity of its Magic Lappen product, both of which increased sales across Germany. CBD of Denver also highlighted the success of Libra 9's attendance at trade shows, which boosted brand recognition and allowed the company to form several significant partnerships. Meanwhile, Luxora's expansion into the European CBD wholesale market was credited with contributing significantly to the company's growth. Following the German government's expected approval of relevant legislation, Luxora Solutions will expand further into the German market. Germany's decision on legalising marijuana, which was set to be made in December, has been delayed until next year.

CBDD

Read More

Earnings Outlook For Syneos Health

Syneos Health (NASDAQ:SYNH) is set to give its latest quarterly earnings report on Friday, 2022-11-04. Here's what investors need to know before the announcement. Analysts estimate that Syneos Health will report an earnings per share (EPS) of $1.32.

SYNH